The HGF/c-Met signaling pathway affects multiple cellular processes during cancer progression, including cell proliferation, migration, invasion, apoptosis, and drug-resistance (Stein et al., 2009; Sheng et al., 2014; Sueta et al., 2015; Li et al., 2018). This evidence concerns the gene MET and cancer.